Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: Asymptomatic carotid artery stenosis (ACAS) may cause future stroke and therefore patients with ACAS require best medical treatment. Patients at high risk for stroke may opt for additional revascularization (either surgery or stenting) but the future stroke risk should outweigh the risk for peri/post-operative stroke/death. Current risk stratification for patients with ACAS is largely based on outdated randomized-controlled trials that lack the integration of improved medical therapies and risk factor control. Furthermore, recent circulating and imaging biomarkers for stroke have never been included in a risk stratification model. The TAXINOMISIS Project aims to develop a new risk stratification model for cerebrovascular complications in patients with ACAS and this will be tested through a prospective observational multicentre clinical trial performed in six major European vascular surgery centres. METHODS AND ANALYSIS: The risk stratification model will compromise clinical, circulating, plaque and imaging biomarkers. The prospective multicentre observational study will include 300 patients with 50%-99% ACAS. The primary endpoint is the three-year incidence of cerebrovascular complications. Biomarkers will be retrieved from plasma samples, brain MRI, carotid MRA and duplex ultrasound. The TAXINOMISIS Project will serve as a platform for the development of new computer tools that assess plaque progression based on radiology images and a lab-on-chip with genetic variants that could predict medication response in individual patients. CONCLUSION: Results from the TAXINOMISIS study could potentially improve future risk stratification in patients with ACAS to assist personalized evidence-based treatment decision-making.

Original publication

DOI

10.1111/eci.13411

Type

Journal article

Journal

Eur J Clin Invest

Publication Date

12/2020

Volume

50

Keywords

biomarker, carotid artery stenosis, pharmacogenetics, risk stratification, Aged, Anticoagulants, Asymptomatic Diseases, Biomarkers, Carotid Stenosis, Clinical Decision Rules, Disease Progression, Endarterectomy, Carotid, Endovascular Procedures, Female, Humans, Hypolipidemic Agents, Lab-On-A-Chip Devices, Male, Middle Aged, Models, Theoretical, Pharmacogenomic Testing, Platelet Aggregation Inhibitors, Prospective Studies, Risk Assessment, Stents, Stroke